Literature DB >> 15976596

Comparison of acute and subclinical pelvic inflammatory disease.

Harold C Wiesenfeld1, Richard L Sweet, Roberta B Ness, Marijane A Krohn, Anthony J Amortegui, Sharon L Hillier.   

Abstract

OBJECTIVE: The objective of this study was to compare the demographic, clinical, and microbiologic findings in women with subclinical pelvic inflammatory disease (PID) and women with acute PID. STUDY: A cross-sectional study was performed using cohorts from 2 separate studies of 1293 women at risk for PID. Most participants were recruited from emergency departments, sexually transmitted disease clinics, and family planning clinics in metropolitan centers. We compared demographic, clinical, and microbiologic findings among women with acute PID, women with subclinical PID, and women without endometritis (controls). Statistical analyses included chi-square for categorical variables, calculation of odds ratio and 95% confidence intervals, and polychotomous logistic regression when appropriate.
RESULTS: Similar proportions of women with acute and subclinical PID tested positive for cervical Chlamydia trachomatis (odds ratio [OR], 1.1; 95% confidence interval, 0.6-2.0) and had bacterial vaginosis (OR, 0.7; 95% CI, 0.2-1.8). The rate of cervical Neisseria gonorrhoeae infection in women with subclinical PID was intermediate between the rates in women with acute PID and controls (21% vs. 49% vs. 7%, respectively, P <0.001, test for trend). Endometrial recovery of N. gonorrhoeae and C. trachomatis in women with subclinical PID was also seen at intermediate levels. Similar distributions of teenagers, women who smoked or used illicit drugs, and women engaging in sexual intercourse during menses were found in each group. Proportions of women with subclinical PID who were black and with lower education levels were intermediate between the proportions of these characteristics in women with acute PID and controls.
CONCLUSION: Demographic and microbiologic characteristics of women with subclinical and acute PID are comparable. These findings suggest that the pathophysiological mechanisms of acute and subclinical PID are similar.

Entities:  

Mesh:

Year:  2005        PMID: 15976596     DOI: 10.1097/01.olq.0000154508.26532.6a

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  31 in total

1.  Pelvic Inflammatory Disease: Current Concepts of Diagnosis and Management.

Authors:  Richard L Sweet
Journal:  Curr Infect Dis Rep       Date:  2012-02-02       Impact factor: 3.725

2.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

3.  Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study.

Authors:  N Low; M Egger; J A C Sterne; R M Harbord; F Ibrahim; B Lindblom; B Herrmann
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

Review 4.  Pelvic inflammatory disease.

Authors:  Maria Trent
Journal:  Pediatr Rev       Date:  2013-04

Review 5.  Status of adolescent pelvic inflammatory disease management in the United States.

Authors:  Maria Trent
Journal:  Curr Opin Obstet Gynecol       Date:  2013-10       Impact factor: 1.927

6.  2GETHER - The Dual Protection Project: Design and rationale of a randomized controlled trial to increase dual protection strategy selection and adherence among African American adolescent females.

Authors:  Alexander C Ewing; Melissa J Kottke; Joan Marie Kraft; Jessica M Sales; Jennifer L Brown; Peggy Goedken; Jeffrey Wiener; Athena P Kourtis
Journal:  Contemp Clin Trials       Date:  2016-12-19       Impact factor: 2.226

Review 7.  Sexually transmitted diseases and infertility.

Authors:  Danielle G Tsevat; Harold C Wiesenfeld; Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2017-01       Impact factor: 8.661

8.  Maternal self-reported genital tract infections during pregnancy and the risk of selected birth defects.

Authors:  Tonia C Carter; Richard S Olney; Allen A Mitchell; Paul A Romitti; Erin M Bell; Charlotte M Druschel
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-12-07

9.  Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope.

Authors:  Ye Zhu; Janina Jiang; Najwane Said-Sadier; Gale Boxx; Cheryl Champion; Ashley Tetlow; Valerie A Kickhoefer; Leonard H Rome; David M Ojcius; Kathleen A Kelly
Journal:  Vaccine       Date:  2014-11-24       Impact factor: 3.641

10.  Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Toni Darville; Robert E Ferrell; Candace M Kammerer; Roberta B Ness; Catherine L Haggerty
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.